Press Releases
Oct 12, 2021

Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced that patient enrollment was completed in Cohort K of the phase...

Sep 28, 2021

Seramount (formerly Working Mother Media) revealed its annual list of the 2021 100 Best Companies today, marking the seventh consecutive year Astellas is ranked as a top company for working moms....

Sep 27, 2021

Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has...

EXPLORE ALL US PRESS RELEASES

Articles
Oct 8, 2021

The article below, co-authored by Mark Reisenauer, president of Astellas Pharma US, Tim Walbert, chairman, president and CEO of Horizon Therapeutics, and Peter Anastasiou, executive vice president...

Sep 28, 2021

Astellas was recently ranked in Seramount’s (formerly Working Mother Media) 2021 100 Best Companies and Best Companies for Dads lists. We recognize Carrie Schimizzi, Executive Director,...

Aug 4, 2021

Astellas is committed to partnering with national and local non-profit organizations to help improve access to healthcare for underserved groups in the United States. In Fiscal Year 2020, the...

EXPLORE ALL ARTICLES

Stay Connected

Get only the email alerts you want.

Subscribe

Media Contacts

corporate.communications@astellas.com

800-888-7704
(press menu option 5, then option 2)
This line is monitored between 8:00am-4:30-pm Central Time M-F

For inquiries during non-business hours, please contact us

 

Astellas on Twitter
Download Fact Sheet
Sustainability
Investors
Explore U.S. Products